| Literature DB >> 31330522 |
Victoria Wurcel1, Americo Cicchetti2, Louis Garrison3, Michelle M A Kip4, Hendrik Koffijberg4, Anne Kolbe5, Mariska M G Leeflang6, Tracy Merlin7, Jorge Mestre-Ferrandiz8, Wija Oortwijn9, Cor Oosterwijk10, Sean Tunis11, Bernarda Zamora12.
Abstract
Health systems around the world seek to address patients' unmet health needs for a range of acute and chronic diseases. Simultaneously, governments strive to keep healthcare spending sustainable, while providing equal access to high-quality care. This has fuelled debate around what constitutes a valuable healthcare intervention in a health system and the corollary consideration of what governments are willing to pay for a certain health intervention. Until recently, the value of information in general, and the value of diagnostic information (VODI) specifically, was not part of the discussion.However, investment in diagnostic information can be a key development as information may guide more effective and efficient healthcare and help maintain an affordable health system. This paper therefore explores ways to best define, evaluate, and reward the value created from diagnostics in healthcare and how to include these value considerations in decision-making processes for diagnostics. The authors ultimately call for a holistic VODI framework that accounts for the full range of potential benefits of diagnostic testing, beyond the traditional clinical and health economic domains, and that is essential to recognise, measure, and fully leverage the benefits of diagnostics for patients, health systems, and society.Entities:
Keywords: Access to healthcare; Decision-making; Diagnostics information; EU policy; Health economics; Healthcare services; Personalized medicine
Year: 2019 PMID: 31330522 DOI: 10.1159/000501832
Source DB: PubMed Journal: Public Health Genomics ISSN: 1662-4246 Impact factor: 2.000